Mefipic Oral Suspension Mango is a combination analgesic and antipyretic formulation containing Mefenamic Acid (100 mg) and Paracetamol (250 mg) per 5 ml. Mefenamic Acid, a nonsteroidal anti-inflammatory drug (NSAID), exerts its therapeutic effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol, a widely used analgesic and antipyretic agent, acts centrally to alleviate pain and reduce fever through inhibition of prostaglandin synthesis in the central nervous system. This oral suspension is indicated for the management of mild to moderate pain, including musculoskeletal pain, dental pain, dysmenorrhea, and fever associated with various conditions. The mango-flavored formulation enhances palatability, making it suitable for pediatric and adult patients who have difficulty swallowing tablets. Mefipic Oral Suspension should be administered according to the prescribed dosage, taking care to avoid concomitant use with other products containing paracetamol or NSAIDs to prevent overdose and adverse effects. Common side effects may include gastrointestinal discomfort, nausea, or allergic reactions. Caution is advised in patients with hepatic, renal, or cardiovascular impairment. Consultation with a healthcare professional is recommended before use, especially in pregnant or breastfeeding women.